Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics Statistics

Total Valuation

DFTX has a market cap or net worth of $1.83 billion. The enterprise value is $1.46 billion.

Market Cap	1.83B
Enterprise Value	1.46B

Important Dates

The last earnings date was Thursday, February 26, 2026, after market close.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

DFTX has 99.70 million shares outstanding. The number of shares has increased by 26.78% in one year.

Current Share Class	99.70M
Shares Outstanding	99.70M
Shares Change (YoY)	+26.78%
Shares Change (QoQ)	+17.60%
Owned by Insiders (%)	0.96%
Owned by Institutions (%)	63.26%
Float	93.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.45
P/TBV Ratio	5.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.29, with a Debt / Equity ratio of 0.12.

Current Ratio	6.29
Quick Ratio	6.17
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-30.34

Financial Efficiency

Return on equity (ROE) is -64.06% and return on invested capital (ROIC) is -32.68%.

Return on Equity (ROE)	-64.06%
Return on Assets (ROA)	-28.01%
Return on Invested Capital (ROIC)	-32.68%
Return on Capital Employed (ROCE)	-44.54%
Weighted Average Cost of Capital (WACC)	18.81%
Revenue Per Employee	n/a
Profits Per Employee	-$1.73M
Employee Count	106
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +188.50% in the last 52 weeks. The beta is 2.68, so DFTX's price volatility has been higher than the market average.

Beta (5Y)	2.68
52-Week Price Change	+188.50%
50-Day Moving Average	16.70
200-Day Moving Average	11.91
Relative Strength Index (RSI)	58.11
Average Volume (20 Days)	1,573,592

Short Selling Information

The latest short interest is 19.34 million, so 19.40% of the outstanding shares have been sold short.

Short Interest	19.34M
Short Previous Month	19.51M
Short % of Shares Out	19.40%
Short % of Float	20.64%
Short Ratio (days to cover)	13.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-166.31M
Pretax Income	-183.79M
Net Income	-183.79M
EBITDA	-166.28M
EBIT	-166.31M
Earnings Per Share (EPS)	-$2.06

Balance Sheet

The company has $411.59 million in cash and $40.58 million in debt, with a net cash position of $371.01 million or $3.72 per share.

Cash & Cash Equivalents	411.59M
Total Debt	40.58M
Net Cash	371.01M
Net Cash Per Share	$3.72
Equity (Book Value)	332.33M
Book Value Per Share	3.36
Working Capital	352.62M

Cash Flow

Operating Cash Flow	-131.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DFTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.78%
Shareholder Yield	-26.78%
Earnings Yield	-10.06%
FCF Yield	n/a

Analyst Forecast

The average price target for DFTX is $40.25, which is 119.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.25
Price Target Difference	119.71%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 29, 2022
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1